{
    "Trade/Device Name(s)": [
        "JBAIDS Influenza A & B Detection Kit"
    ],
    "Submitter Information": "The Surgeon General, Department of the Army",
    "510(k) Number": "K152523",
    "Predicate Device Reference 510(k) Number(s)": [
        "K111775"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC"
    ],
    "Summary Letter Date": "September 2, 2015",
    "Summary Letter Received Date": "September 3, 2015",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A virus RNA",
        "Influenza B virus RNA"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Nasopharyngeal wash"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "JBAIDS Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Reverse transcriptase real-time PCR (rRT-PCR)",
        "Hydrolysis probe-based PCR"
    ],
    "Methodologies": [
        "RT-PCR",
        "Qualitative nucleic acid detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for JBAIDS Influenza A & B Detection Kit utilizing rRT-PCR for qualitative detection of influenza A and B viral RNA on JBAIDS instruments",
    "Indications for Use Summary": "Intended for use on JBAIDS instruments for in vitro qualitative detection of influenza A and B viral nucleic acids in nasopharyngeal swab and wash specimens from patients with respiratory infection signs and symptoms",
    "fda_folder": "Microbiology"
}